Identification of cells for transplantation

Abstract

Pluripotent cells that are suitable for transplantation therapy, to repair neural damage, are identified, e.g. by differential display, from a gene expression profile for a selected cell, which can be compared with that obtained from a control cell.

We claim:  
     
         1 . A method for determining the suitability of a candidate cell for transplantation into a damaged vertebrate brain for the purpose of repairing damage to the brain, wherein said method comprises: 
 (i) selecting a candidate cell with a neural cell phenotype, or that is capable of differentiating into a cell with a neural cell phenotype;    (ii) obtaining the gene expression profile of said candidate cell;    (iii) identifying a gene expression profile common to a plurality of control cells known to be suitable for transplantation;    (iv) comparing the gene expression profile of said candidate cell with the gene expression profile common to said plurality of control cells; and    (v) identifying said candidate cell as being suitable for transplantation if said candidate cell shares the gene expression profile of said plurality of control cells.    
     
     
         2 . The method, according to  claim 1 , wherein said plurality of control cells does not express the gene Pax6 or 3R2C.  
     
     
         3 . The method, according to  claim 1 , wherein said plurality of control cells comprises an MHP36 cell and a different control cell.  
     
     
         4 . The method, according to  claim 1 , wherein step (ii) is carried out by differential display.  
     
     
         5 . The method, according to  claim 1 , wherein the gene expression profile common to said plurality of control cells comprises two or more expressed genes.  
     
     
         6 . The method, according to  claim 1 , wherein the gene expression profile common to said plurality of control cells comprises two or more non-expressed genes.  
     
     
         7 . The method, according to  claim 1 , wherein the gene expression profile common to said plurality of control cells comprises at least one expressed gene selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, and SEQ ID NO. 5.  
     
     
         8 . The method, according to  claim 1 , wherein the gene expression profile common to said plurality of control cells comprises at least one non-expressed gene selected from the group consisting of SEQ ID NO. 6 and SEQ ID NO. 7.  
     
     
         9 . The method, according to  claim 1 , wherein the gene expression profile common to said plurality of control cells comprises at least one expressed gene selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, and SEQ ID NO. 5, and at least one non-expressed gene selected from the group consisting of SEQ ID NO. 6 and SEQ ID NO. 7.  
     
     
         10 . The method, according to  claim 1 , wherein said candidate cell is undifferentiated.  
     
     
         11 . The method, according to  claim 1 , wherein said candidate cell is multipotent.  
     
     
         12 . A method for identifying a gene, the expression of which can determine whether or not a neural cell can repair a damaged brain, wherein said method comprises: 
 (i) selecting a candidate cell with a neural cell phenotype, or that is capable of differentiating into a cell with a neural cell phenotype;    (ii) obtaining the gene expression profile of said candidate cell;    (iii) identifying a gene expression profile common to a plurality of control cells known to be suitable for transplantation;    (iv) comparing the gene expression profile of said candidate cell with the gene expression profile common to said plurality of control cells; and    (v) identifying a gene within said gene expression profile of said candidate cell or within said gene expression profile common to said plurality of control cells, wherein said gene is expressed within said candidate cell but is not expressed within said plurality of control cells, or wherein said gene is not expressed within said candidate cell but is expressed within said plurality of control cells.    
     
     
         13 . The method, according to  claim 12 , wherein said plurality of control cells does not express the gene Pax6 or 3R2C.  
     
     
         14 . The method, according to  claim 12 , wherein said plurality of control cells comprises an MHP36 cell and a different control cell.  
     
     
         15 . The method, according to  claim 12 , wherein step (ii) is carried out by differential display.  
     
     
         16 . The method, according to  claim 12 , wherein the gene expression profile common to said plurality of control cells comprises two or more expressed genes.  
     
     
         17 . The method, according to  claim 12 , wherein the gene expression profile common to said plurality of control cells comprises two or more non-expressed genes.  
     
     
         18 . The method, according to  claim 12 , wherein the gene expression profile common to said plurality of control cells comprises at least one expressed gene selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, and SEQ ID NO. 5.  
     
     
         19 . The method, according to  claim 12 , wherein the gene expression profile common to said plurality of control cells comprises at least one non-expressed gene selected from the group consisting of SEQ ID NO. 6 and SEQ ID NO. 7.  
     
     
         20 . The method, according to  claim 12 , wherein the gene expression profile common to said plurality of control cells comprises at least one expressed gene selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, and SEQ ID NO. 5, and at least one non-expressed gene selected from the group consisting of SEQ ID NO. 6 and SEQ ID NO. 7.  
     
     
         21 . The method, according to  claim 12 , wherein said candidate cell is undifferentiated.  
     
     
         22 . The method, according to  claim 12 , wherein said candidate cell is multipotent.  
     
     
         23 . A method for selecting a cell suitable for transplantation into a damaged brain, which comprises selecting a candidate cell with a neural cell phenotype, or that is capable of differentiating into a cell with a neural cell phenotype; and determining the expression of a gene comprising a nucleotide sequence selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, and SEQ ID NO. 5 within said candidate cell.